Med-IQ
New Developments in Diagnosing and Treating Hip and Knee Periprosthetic Joint Infection: A Guide for Orthopaedic Surgeons
Med-IQ Express Med-IQ Express

New Developments in Diagnosing and Treating Hip and Knee Periprosthetic Joint Infection: A Guide for Orthopaedic Surgeons


This activity was developed by Med-IQ in collaboration with Duke University Health System Department of Clinical Education and Professional Development.

Med-IQ      Duke Medicine
 

Time to Complete:
15 minutes
Released:
10/16/17
Expires:
10/15/18

Maximum Credits:

0.25 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Med-IQ Express Med-IQ Express
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
15 minutes

Released:
10/16/17

Expires:
10/15/18

Maximum Credits:
0.25 AMA PRA Category 1 Credit(s)
Share on:
Med-IQ Express Med-IQ Express
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
15 minutes
Released:
10/16/17
Expires:
10/15/18


Maximum Credits:
0.25 AMA PRA Category 1 Credit(s)


Overview: This 15-minute publication begins with a brief video in which a clinical expert reviews recent changes in the diagnosis of periprosthetic joint infection (PJI), including Musculoskeletal Infection Society criteria and newly identified synovial biomarkers. The publication then discusses approaches for confirming a diagnosis of PJI and reviews available treatment strategies, including surgical and pharmacologic options.

Faculty

William Jiranek, MD, FACS

Professor of Orthopaedic Surgery

Duke University School of Medicine

Durham, NC


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

William Jiranek, MD, FACS
Royalty: DePuy Synthes
Consulting fees/advisory boards: DePuy Synthes

The writer, peer reviewers, and activity planners have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.